Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Buy
168
+100
+147% +$9.92K ﹤0.01% 464
2026
Q1
$6.4K Buy
+68
New +$6.79K ﹤0.01% 454
2025
Q2
Sell
-186
Closed -$11.3K 420
2025
Q1
$11.3K Hold
186
﹤0.01% 393
2024
Q4
$12.7K Sell
186
-524
-74% -$37.3K ﹤0.01% 403
2024
Q3
$46.9K Sell
710
-250
-26% -$15.9K ﹤0.01% 345
2024
Q2
$58.2K Sell
960
-270
-22% -$15.3K ﹤0.01% 390
2024
Q1
$70.1K Buy
+1,230
New +$73.8K ﹤0.01% 385

Other funds holding INCY

Allianz's INCY Position: Q2 2026 in Review

Allianz increased its Incyte (INCY) stake by 147% in Q2 2026, buying an estimated $9.92K and bringing the position to 168 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Allianz first reported a position in INCY in Q1 2024 and has held it in 7 quarters since. The position peaked at $70.1K in Q1 2024. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Allianz held 168 shares of Incyte worth $19K as of Q2 2026.
  • Allianz bought 100 Incyte shares in Q2 2026, an estimated $9.92K.
  • Incyte made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #464 holding.
  • Allianz first reported a position in Incyte in Q1 2024 and has held it in 7 quarters since.
  • Allianz's Incyte position peaked at $70.1K in Q1 2024.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.